Literature DB >> 7667378

Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex.

M Yoshioka1, M Matsumoto, H Togashi, H Saito.   

Abstract

The effects of conditioned fear stress (CFS) on 5-HT release in the medial prefrontal cortex were studied by in vivo microdialysis. CFS (exposure to an environment in which foot-shock had been delivered previously) induced a marked suppression of motility-that is, freezing behavior. The extracellular concentration of 5-HT in the medial prefrontal cortex increased during this freezing behavior, but no significant changes were observed in the concentration of its metabolite, 5-HIAA. The increased 5-HT concentration returned to pretreatment levels when the animals were returned to their home cages. Diazepam (0.5 mg/kg, intraperitoneally) reduced the CFS-induced freezing behavior and prevented the increases in extracellular 5-HT levels. A 5-HT3 receptor antagonist, tropisetron (10 and 100 micrograms/kg), also inhibited both the CFS-induced increase in 5-HT release and the freezing behavior. These findings suggest that there is a relationship between anxiety and 5-HT release in the prefrontal cortex and that the 5-HT3 receptor antagonist tropisetron might have anxiolytic properties.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7667378     DOI: 10.1016/0091-3057(95)00045-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  22 in total

1.  Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system.

Authors:  C A Lowry; J E Rodda; S L Lightman; C D Ingram
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 2.  Opponency revisited: competition and cooperation between dopamine and serotonin.

Authors:  Y-Lan Boureau; Peter Dayan
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

3.  Lesions of the habenula produce stress- and dopamine-dependent alterations in prepulse inhibition and locomotion.

Authors:  Scott A Heldt; Kerry J Ressler
Journal:  Brain Res       Date:  2006-01-24       Impact factor: 3.252

4.  The serotonergic projection from the median raphe nucleus to the ventral hippocampus is involved in the retrieval of fear memory through the corticotropin-releasing factor type 2 receptor.

Authors:  Yu Ohmura; Takeshi Izumi; Taku Yamaguchi; Iku Tsutsui-Kimura; Takayuki Yoshida; Mitsuhiro Yoshioka
Journal:  Neuropsychopharmacology       Date:  2010-01-13       Impact factor: 7.853

5.  Brief light as a practical aversive stimulus for the albino rat.

Authors:  David J Barker; Federico Sanabria; Anne Lasswell; Eric A Thrailkill; Anthony P Pawlak; Peter R Killeen
Journal:  Behav Brain Res       Date:  2010-06-19       Impact factor: 3.332

Review 6.  Behavioral characteristics and neurobiological substrates shared by Pavlovian sign-tracking and drug abuse.

Authors:  Arthur Tomie; Kathryn L Grimes; Larissa A Pohorecky
Journal:  Brain Res Rev       Date:  2007-12-28

Review 7.  Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease.

Authors:  Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2008-03-26       Impact factor: 8.989

8.  Aggressive encounters alter the activation of serotonergic neurons and the expression of 5-HT1A mRNA in the hamster dorsal raphe nucleus.

Authors:  M A Cooper; M S Grober; C R Nicholas; K L Huhman
Journal:  Neuroscience       Date:  2009-04-09       Impact factor: 3.590

9.  Effects of dexfenfluramine and 5-HT3 receptor antagonists on stress-induced reinstatement of alcohol seeking in rats.

Authors:  Anh Dzung Lê; Douglas Funk; Stephen Harding; W Juzytsch; Paul J Fletcher; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2006-03-07       Impact factor: 4.530

10.  Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist.

Authors:  Nesha S Burghardt; David E A Bush; Bruce S McEwen; Joseph E LeDoux
Journal:  Biol Psychiatry       Date:  2007-05-23       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.